RRIDs were included in the Cancer Research paper "STIM1 Mediates Calcium-dependent Epigenetic Reprog…" (https://t.co/EWbsbRiwFv). We appreciate the author's support of reproducibility. #methodsmatter #RRID
STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer https://t.co/A1smeXG9vy
STIM1 Mediates Calcium-dependent Epigenetic Reprogramming in Pancreatic Cancer | Cancer Research https://t.co/bPH5KhxpzN
RT @ItalianPCC: Co-amplification of RRM1 and STIM1 leads to gemcitabine resistance through Ca-dependent mechanisms. #pancreaticcancer https…
RT @MC_Hasselluhn: Gemcitabine has been our weapon of choice against @pancreaticcancer since 1997. But what happens when cells gain resista…
RT @IMPRS_GS: We are proud that our alumni @MonkyXin was part of the team. Congratulations to him and @ProfJohnsen. 🧬@uniGoettingen @IMPRS_…
RT @MC_Hasselluhn: Gemcitabine has been our weapon of choice against @pancreaticcancer since 1997. But what happens when cells gain resista…
STIM1 Mediates Calcium-dependent Epigenetic Reprogramming in Pancreatic Cancer. https://t.co/JUHIY8cHOS
RT @ProfJohnsen: Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabi…
We are proud that our alumni @MonkyXin was part of the team. Congratulations to him and @ProfJohnsen. 🧬@uniGoettingen @IMPRS_GS
RT @ProfJohnsen: Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabi…
RT @MC_Hasselluhn: Gemcitabine has been our weapon of choice against @pancreaticcancer since 1997. But what happens when cells gain resista…
Co-amplification of RRM1 and STIM1 leads to gemcitabine resistance through Ca-dependent mechanisms. #pancreaticcancer https://t.co/kXh7SQC4qH?
RT @ProfJohnsen: Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabi…
Gemcitabine has been our weapon of choice against @pancreaticcancer since 1997. But what happens when cells gain resistance? Check out the latest work of the team around @ProfJohnsen to read about STIM1 amplification in gemcitabine-resistant PDAC
RT @ProfJohnsen: Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabi…
RT @ProfJohnsen: Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabi…
RT @ProfJohnsen: Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabi…
RT @ProfJohnsen: Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabi…
RT @ProfJohnsen: Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabi…
Our newest work is now online @CR_AACR Here we describe how “collateral” amplification of STIM1 during acquired #gemcitabineresistance enables #pancreaticcancer cells to divert cell stress signals to pro-tumorigenic Ca2+ signaling. https://t.co/d1Pc1Wbu4Z